Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
People may eat more calories after stopping weight loss drugs, according to Deutsche Bank survey
Tags stocks Eli Lilly and Co Novo Nordisk A/S
From CNBC.com News
Biden administration's Medicare drug price negotiations will face major tests in 2024
Tags Prescription drugs Politics AstraZeneca PLC
From CNBC.com News
Here are the big health sector themes to watch next year
Tags Eli Lilly and Co Humana Inc Novo Nordisk A/S
From CNBC.com News
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Health & Science
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Investing Markets Technology
From CNBC.com News
The weight loss drug boom isn't over yet — here's what to expect in the year ahead
Tags Pfizer Inc Altimmune Inc Health care industry
From CNBC.com News
Patients regain weight after stopping Eli Lilly's Zepbound, study says
Tags Science Novo Nordisk A/S Breaking news
From CNBC.com News
Eli Lilly weight loss drug Zepbound now available at pharmacies as rival Wegovy faces shortages
Tags US: News Business News Biotechnology
From CNBC.com News
An EU wealth tax and the end of U.S. capitalism: One bank’s ‘outrageous’ predictions for 2024
Tags Europe Politics Breaking News: Economy Breaking News: Markets
From CNBC.com News
Cramer says the growing popularity of weight loss drugs brings new investing opportunities
Tags Jacobs Solutions Inc Stock markets U/S/ Markets
From CNBC.com News
Pfizer's twice-daily weight loss pill joins a long list of obesity drug flops
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Science
From CNBC.com News
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
Tags Eli Lilly and Co Business Health & Science
From CNBC.com News
Novo Nordisk sues two pharmacies for allegedly selling tainted Wegovy, Ozempic knockoffs
Tags Pharmaceuticals Companies Health care industry
From CNBC.com News
Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real world study says
Tags Eli Lilly and Co Business Health & Science
From CNBC.com News
Jim Cramer says insurance companies will pay for 'revolutionary' weight-loss drugs for their members
Tags Business Eli Lilly and Co stocks
From CNBC.com News
Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success
Tags Pharmaceuticals Companies Health care industry
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Business Politics Economy
From CNBC.com News
Novo Nordisk's weight loss drug Wegovy slashes risk of serious heart events
Tags Business News Novo Nordisk A/S Science
From CNBC.com News
Cramer's week ahead: Consumer spending in the spotlight with retail earnings and a new price index
Tags Business News Stock markets Macy's Inc
From CNBC.com News
Cramer's Lightning Round: Buy AutoZone
Tags Broadcom Inc Investment Strategy Novo Nordisk A/S
From CNBC.com News
FDA approves Eli Lilly's tirzepatide for obesity, paving way for even wider use of blockbuster drug
Tags Health & Science Social issues Business
From CNBC.com News
Novo Nordisk says 80% of insured U.S. patients taking Wegovy pay less than $25 a month
Tags Business News Biotechnology US: News
From CNBC.com News
Eli Lilly says supply of blockbuster diabetes drug Mounjaro has improved in U.S.
Tags Breaking news Biotech and Pharmaceuticals US: News
From CNBC.com News
Weight-loss drug Wegovy could get expanded FDA approval within six months, Novo Nordisk says
Tags Novo Nordisk A/S Biotechnology Business News
From CNBC.com News
Eli Lilly results top estimates on Mounjaro strength but slashes full-year profit outlook
Tags Health & Science Eli Lilly and Co Business
From CNBC.com News
Pfizer swings to quarterly loss due to Paxlovid, Covid vaccine write-offs
Tags Earnings Business News Biotechnology
From CNBC.com News
As Ozempic and Wegovy take off, this tech startup just raised $20 million to tackle weight loss with data
Tags Health care industry Technology Dexcom Inc
From CNBC.com News
CNBC Daily Open: Oil deals ahead of Big Tech earnings
Tags Inflation Novo Nordisk A/S Prices
From CNBC.com News
CNBC Daily Open: Oil deals and awaiting tech earnings
Tags Inflation Novo Nordisk A/S Asia Markets
From CNBC.com News
Wall Street hikes forecasts for anti-obesity drug sales to $100 billion and beyond — A look at the numbers
Tags Health & Science Eli Lilly and Co Health care industry
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.